SNTI vs SYK · rev $33.0K vs P/E 35, rev $6.59B
Senti Biosciences Inc (SNTI) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported SNTI revenue for 2026-06-30 was $33.0K. Net income was -$17.0M. SNTI currently screens at market cap $29.6M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
SNTI currently screens at market cap $29.6M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the SNTI and SYK stock pages for the full models.
Not investment advice.